Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Lysosomal Diseases Testing Laboratory Thomas Jefferson University United States | 58 | 18 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 73 | 61 |
|
Tay-Sachs: HexA gene sequencing Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 1 | 1 |
|
Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 1 | 1 |
|
Lysosomal storage disorder by enzyme study from amniotic fluid and CVS Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 24 | 23 |
|
Cherry red spot and Neuroregression panel Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 7 | 6 |
|
Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 6 | 6 |
|
Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 1 | 1 |
|
Lysosomal Storage Disease Panel Molecular Genetics Laboratory London Health Sciences Centre Canada | 77 | 50 |
|
Centogene AG - the Rare Disease Company Germany | 195 | 221 |
|
CentoXome MOx (Whole Exome Sequencing) Centogene AG - the Rare Disease Company Germany | 13 | 19 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
Centogene AG - the Rare Disease Company Germany | 12 | 18 |
|
Centogene AG - the Rare Disease Company Germany | 12 | 36 |
|
Centogene AG - the Rare Disease Company Germany | 10 | 10 |
|
Centogene AG - the Rare Disease Company Germany | 10 | 20 |
|
HEXA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 164 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.